Spago Nanomedical AB (publ)

Spago Nanomedical AB (publ) is a Swedish clinical phase company, developing products for treatment and imaging diagnostics of cancer and other severe diseases.

Anyone who was a shareholder in Spago Nanomedical AB (publ) on the record date of May 29, 2026 has preferential rights to subscribe for shares, in relation to previous shareholdings. Anyone who is a registered shareholder on the record date shall recieve one (1) subscription right for each held share in Spago Nanomedical AB. To subscribe for two (2) new shares at the subscription price of 0.11 SEK per share, nine (9) subscription rights are needed. For subscription without subscription rights, the above registration form can be used. When subscribing via ISK/KF accounts, subscription must be made in agreement with the bank/custodian where the account is located